This Future Tech TOE depicts trends across smart pills and ingestible sensors. Endoscopic imaging, real-time sensing, targeted drug delivery, and surgery appear as the key applications and areas of growth. Drivers and challenges, convergence of innovation, global adoption, intellectual property trends and market support are also illustrated. The corresponding patent scenario is depicted along with the industry interactions.
The Future Tech TechVision Opportunity Engine (TOE) captures emerging innovations in research and development, or profile existing technologies which have seen a resurgence in terms of new markets and applications. It usually provides a technology overview, drivers, challenges, research and development, analyst insights and key patent information. In some cases, technology convergence scenarios and future growth opportunities are outlined. It covers innovations and technologies in a variety of industry spaces including manufacturing, sensors, electronics, information and communications technologies, networks, lighting technologies, healthcare, medical devices, materials and coatings, and developments in the energy sector that contribute toward a sustainable and greener world.
The need for low power, smaller, lighter sensors with enhanced performance attributes and minimal false alarms is driving innovations in the sensors space. The Sensors and Instrumentation cluster covers innovations pertaining to technologies such as wireless sensors and networks, energy harvesting, haptics and touch, MEMS and nanosensors, Terahertz, ubiquitous/smart sensors, CBRNE, quantified-self, sensor fusion, M2M communications, and drones.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Keywords: Smart pills, ingestible sensors, diagnostic imaging, vital signs monitoring, targeted drug delivery, next generation surgery